These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6221997)

  • 1. Mechanism of immunosuppression in leprosy: presence of suppressor factor(s) from macrophages of lepromatous patients.
    Salgame PR; Mahadevan PR; Antia NH
    Infect Immun; 1983 Jun; 40(3):1119-26. PubMed ID: 6221997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
    Sasiain MD; de la Barrera S; Valdez R; Balina LM
    Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
    Nath I; Van Rood JJ; Mehra NK; Vaidya MC
    Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concanavalin A induced suppressor activity in human leprosy.
    Nath I; Narayanan RB; Mehra NK; Sharma AK; Gupte MD
    J Clin Lab Immunol; 1979 Nov; 2(4):319-24. PubMed ID: 161322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of in vitro T cell responsiveness in lepromatous leprosy.
    Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA
    J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
    Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA
    J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.
    Desai SD; Birdi TJ; Antia NH
    Infect Immun; 1989 Apr; 57(4):1311-7. PubMed ID: 2494115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
    Nath I; Singh R
    Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium leprae-reactive T-cell clones isolated from polar lepromatous and tuberculoid leprosy patients.
    Launois P; Shankar P; Wallach D; Flageul B; Cottenot F; Bach MA
    Ann Inst Pasteur Immunol; 1987; 138(5):723-35. PubMed ID: 2830893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lepromin-induced suppressor cells in lepromatous leprosy.
    Nelson EE; Wong L; Uyemura K; Rea TH; Modlin RL
    Cell Immunol; 1987 Jan; 104(1):99-104. PubMed ID: 2948676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
    Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal by interleukin-2 of the T cell unresponsiveness of lepromatous leprosy to Mycobacterium leprae.
    Haregewoin A; Mustafa AS; Helle I; Waters MF; Leiker DL; Godal T
    Immunol Rev; 1984 Aug; 80():77-86. PubMed ID: 6386665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Mycobacterium leprae-specific T-cell deficiency in lepromatous leprosy.
    Bach MA; Launois P
    Biochimie; 1988 Aug; 70(8):1013-8. PubMed ID: 3147697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of T-cell unresponsiveness in leprosy.
    Bach MA; Hoffenbach A; Lagrange PH; Wallach D; Cottenot F
    Ann Immunol (Paris); 1983; 134D(1):75-84. PubMed ID: 6226239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population.
    Stoner GL; Mshana RN; Touw J; Belehu A
    Scand J Immunol; 1982 Jan; 15(1):33-48. PubMed ID: 6176016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors.
    Mohagheghpour N; Gelber RR; Engleman EG
    J Immunol; 1987 Jan; 138(2):570-4. PubMed ID: 2947952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.